← Open Payments lookup

CARLOS VELA: Open Payments

NPI 1124219639 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,070 in 50 payments from 13 companies in 2025. Trend: 2023 $2,081 · 2024 $2,590 · 2025 $2,070

Food & beverage: $2,070
CompanyPaymentsAmount
Amgen Inc.14$415
Dexcom, Inc.4$398
Abbott Laboratories5$241
Novo Nordisk Inc11$238
Optinose US, Inc.4$180
Lilly USA, LLC4$140
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$124
Vifor Pharma, Inc.1$120
Inspire Medical Systems, Inc.1$119
AstraZeneca Pharmaceuticals LP2$37

Products named: REPATHA, Dexcom G6 Transmitter, JOT DX, Xhance, Ozempic, MOUNJARO, XIFAXAN, Veltassa.

Industry payments across TX — which companies pay providers there.